- cross-posted to:
- nyt_gift_articles
- cross-posted to:
- nyt_gift_articles
In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing the companies.
In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing the companies.
By “middlemen” does she mean “the insurance industry”?
The article details issues with pharmaceutical benefit managers, which 2 of the big 3 are owned by insurance companies and the third is owned by CVS
CVS is also selling insurance now btw